Release Date: 28/04/16 19:31 Summary: Broadspectrum Board Changes Recommendation-BRS.AX Price Sensitive: Yes Download Document 136.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%